Neurocrine Biosciences Inc

Advisors Asset Management, Inc. NBIX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/13/2026

Shares

17,488

Value ($000)

2,947

Weight

0.0%

2018 Q2 - 2026 Q2 (32 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/13/2026	2,947	0.0%	17,488	6/30/2026
2026 Q1	5/15/2026	2,504	0.0%	19,006	3/31/2026
2025 Q4	8/21/2026	3,289	0.1%	23,187	12/31/2025
2025 Q3	8/26/2026	4,372	0.1%	31,143	9/30/2025
2025 Q2	8/24/2026	3,983	0.1%	31,689	6/30/2025
2025 Q1	8/26/2026	4,066	0.1%	36,761	3/31/2025
2024 Q4	8/21/2026	4,968	0.1%	36,395	12/31/2024
2024 Q3	8/21/2026	4,445	0.1%	38,576	9/30/2024
2024 Q2	8/21/2026	4,684	0.1%	34,027	6/30/2024
2024 Q1	8/26/2026	4,502	0.1%	32,641	3/31/2024
2023 Q4	8/26/2026	3,022	0.1%	22,933	12/31/2023
2023 Q3	8/26/2026	2,444	0.1%	21,728	9/30/2023
2023 Q2	8/26/2026	2,629	0.1%	27,876	6/30/2023
2023 Q1	8/26/2026	2,823	0.1%	27,888	3/31/2023
2022 Q4	8/27/2026	3,268	0.1%	27,358	12/31/2022
2022 Q3	8/26/2026	2,291	0.0%	21,568	9/30/2022
2022 Q2	8/27/2026	1,970	0.0%	20,207	6/30/2022
2021 Q4	8/27/2026	1,605	0.0%	18,848	12/31/2021
2021 Q3	8/27/2026	1,925	0.0%	20,070	9/30/2021
2021 Q2	8/26/2026	2,161	0.0%	22,210	6/30/2021
2021 Q1	8/26/2026	2,063	0.0%	21,212	3/31/2021
2020 Q4	8/26/2026	1,969	0.0%	20,544	12/31/2020
2020 Q3	8/26/2026	1,705	0.0%	17,734	9/30/2020
2020 Q2	8/27/2026	2,236	0.0%	18,324	6/30/2020
2020 Q1	8/21/2026	1,296	0.0%	14,973	3/31/2020
2019 Q4	8/25/2026	1,359	0.0%	12,643	12/31/2019
2019 Q3	8/18/2026	1,078	0.0%	11,966	9/30/2019
2019 Q2	8/18/2026	619	0.0%	7,330	6/30/2019
2019 Q1	8/18/2026	925	0.0%	10,500	3/31/2019
2018 Q4	8/13/2026	726	0.0%	10,164	12/31/2018
2018 Q3	8/13/2026	864	0.0%	7,030	9/30/2018
2018 Q2	8/13/2026	334	0.0%	3,402	6/30/2018